List of Tables
Table 1. Global Bicyclic Peptide Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bicyclic Peptide Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bicyclic Peptide Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bicyclic Peptide Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bicyclic Peptide Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Bicyclic Peptide Drugs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Bicyclic Peptide Drugs Sales by Region (2020-2025) & (Tons)
Table 8. Global Bicyclic Peptide Drugs Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Bicyclic Peptide Drugs Sales by Manufacturers (2020-2025) & (Tons)
Table 11. Global Bicyclic Peptide Drugs Sales Share by Manufacturers (2020-2025)
Table 12. Global Bicyclic Peptide Drugs Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Bicyclic Peptide Drugs Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Bicyclic Peptide Drugs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bicyclic Peptide Drugs as of 2024)
Table 16. Global Bicyclic Peptide Drugs Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Bicyclic Peptide Drugs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
Table 18. Key Manufacturers Bicyclic Peptide Drugs Manufacturing Base and Headquarters
Table 19. Global Bicyclic Peptide Drugs Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Bicyclic Peptide Drugs Sales by Type (2020-2025) & (Tons)
Table 23. Global Bicyclic Peptide Drugs Sales by Type (2026-2031) & (Tons)
Table 24. Global Bicyclic Peptide Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Bicyclic Peptide Drugs Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Bicyclic Peptide Drugs ASP by Type (2020-2031) & (US$/kg)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Bicyclic Peptide Drugs Sales by Application (2020-2025) & (Tons)
Table 29. Global Bicyclic Peptide Drugs Sales by Application (2026-2031) & (Tons)
Table 30. Bicyclic Peptide Drugs High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Bicyclic Peptide Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Bicyclic Peptide Drugs Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Bicyclic Peptide Drugs ASP by Application (2020-2031) & (US$/kg)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Bicyclic Peptide Drugs Growth Accelerators and Market Barriers
Table 37. North America Bicyclic Peptide Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Bicyclic Peptide Drugs Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Bicyclic Peptide Drugs Growth Accelerators and Market Barriers
Table 40. Europe Bicyclic Peptide Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Bicyclic Peptide Drugs Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Bicyclic Peptide Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Bicyclic Peptide Drugs Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Bicyclic Peptide Drugs Growth Accelerators and Market Barriers
Table 45. Southeast Asia Bicyclic Peptide Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Bicyclic Peptide Drugs Investment Opportunities and Key Challenges
Table 47. Central and South America Bicyclic Peptide Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Bicyclic Peptide Drugs Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Bicyclic Peptide Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Bicycle Therapeutics Corporation Information
Table 51. Bicycle Therapeutics Description and Major Businesses
Table 52. Bicycle Therapeutics Product Models, Descriptions and Specifications
Table 53. Bicycle Therapeutics Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 54. Bicycle Therapeutics Sales Value Proportion by Product in 2024
Table 55. Bicycle Therapeutics Sales Value Proportion by Application in 2024
Table 56. Bicycle Therapeutics Sales Value Proportion by Geographic Area in 2024
Table 57. Bicycle Therapeutics Bicyclic Peptide Drugs SWOT Analysis
Table 58. Bicycle Therapeutics Recent Developments
Table 59. Apellis Pharmaceuticals Corporation Information
Table 60. Apellis Pharmaceuticals Description and Major Businesses
Table 61. Apellis Pharmaceuticals Product Models, Descriptions and Specifications
Table 62. Apellis Pharmaceuticals Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 63. Apellis Pharmaceuticals Sales Value Proportion by Product in 2024
Table 64. Apellis Pharmaceuticals Sales Value Proportion by Application in 2024
Table 65. Apellis Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 66. Apellis Pharmaceuticals Bicyclic Peptide Drugs SWOT Analysis
Table 67. Apellis Pharmaceuticals Recent Developments
Table 68. Merck Corporation Information
Table 69. Merck Description and Major Businesses
Table 70. Merck Product Models, Descriptions and Specifications
Table 71. Merck Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 72. Merck Sales Value Proportion by Product in 2024
Table 73. Merck Sales Value Proportion by Application in 2024
Table 74. Merck Sales Value Proportion by Geographic Area in 2024
Table 75. Merck Bicyclic Peptide Drugs SWOT Analysis
Table 76. Merck Recent Developments
Table 77. Thermo Fisher Corporation Information
Table 78. Thermo Fisher Description and Major Businesses
Table 79. Thermo Fisher Product Models, Descriptions and Specifications
Table 80. Thermo Fisher Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 81. Thermo Fisher Sales Value Proportion by Product in 2024
Table 82. Thermo Fisher Sales Value Proportion by Application in 2024
Table 83. Thermo Fisher Sales Value Proportion by Geographic Area in 2024
Table 84. Thermo Fisher Bicyclic Peptide Drugs SWOT Analysis
Table 85. Thermo Fisher Recent Developments
Table 86. ApexBio Technology Corporation Information
Table 87. ApexBio Technology Description and Major Businesses
Table 88. ApexBio Technology Product Models, Descriptions and Specifications
Table 89. ApexBio Technology Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 90. ApexBio Technology Sales Value Proportion by Product in 2024
Table 91. ApexBio Technology Sales Value Proportion by Application in 2024
Table 92. ApexBio Technology Sales Value Proportion by Geographic Area in 2024
Table 93. ApexBio Technology Bicyclic Peptide Drugs SWOT Analysis
Table 94. ApexBio Technology Recent Developments
Table 95. BPS Bioscience Corporation Information
Table 96. BPS Bioscience Description and Major Businesses
Table 97. BPS Bioscience Product Models, Descriptions and Specifications
Table 98. BPS Bioscience Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 99. BPS Bioscience Recent Developments
Table 100. Selleck Chemicals Corporation Information
Table 101. Selleck Chemicals Description and Major Businesses
Table 102. Selleck Chemicals Product Models, Descriptions and Specifications
Table 103. Selleck Chemicals Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 104. Selleck Chemicals Recent Developments
Table 105. AdooQ BioScience Corporation Information
Table 106. AdooQ BioScience Description and Major Businesses
Table 107. AdooQ BioScience Product Models, Descriptions and Specifications
Table 108. AdooQ BioScience Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 109. AdooQ BioScience Recent Developments
Table 110. Cayman Chemical Company Corporation Information
Table 111. Cayman Chemical Company Description and Major Businesses
Table 112. Cayman Chemical Company Product Models, Descriptions and Specifications
Table 113. Cayman Chemical Company Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 114. Cayman Chemical Company Recent Developments
Table 115. Santa Cruz Biotechnology Corporation Information
Table 116. Santa Cruz Biotechnology Description and Major Businesses
Table 117. Santa Cruz Biotechnology Product Models, Descriptions and Specifications
Table 118. Santa Cruz Biotechnology Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 119. Santa Cruz Biotechnology Recent Developments
Table 120. TargetMol Chemicals Corporation Information
Table 121. TargetMol Chemicals Description and Major Businesses
Table 122. TargetMol Chemicals Product Models, Descriptions and Specifications
Table 123. TargetMol Chemicals Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 124. TargetMol Chemicals Recent Developments
Table 125. Abcam Corporation Information
Table 126. Abcam Description and Major Businesses
Table 127. Abcam Product Models, Descriptions and Specifications
Table 128. Abcam Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 129. Abcam Recent Developments
Table 130. Biotium Corporation Information
Table 131. Biotium Description and Major Businesses
Table 132. Biotium Product Models, Descriptions and Specifications
Table 133. Biotium Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 134. Biotium Recent Developments
Table 135. Cayman Chemical Corporation Information
Table 136. Cayman Chemical Description and Major Businesses
Table 137. Cayman Chemical Product Models, Descriptions and Specifications
Table 138. Cayman Chemical Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 139. Cayman Chemical Recent Developments
Table 140. Apollo Scientific Corporation Information
Table 141. Apollo Scientific Description and Major Businesses
Table 142. Apollo Scientific Product Models, Descriptions and Specifications
Table 143. Apollo Scientific Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 144. Apollo Scientific Recent Developments
Table 145. Tocris Bioscience Corporation Information
Table 146. Tocris Bioscience Description and Major Businesses
Table 147. Tocris Bioscience Product Models, Descriptions and Specifications
Table 148. Tocris Bioscience Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 149. Tocris Bioscience Recent Developments
Table 150. Ningbo Inno Pharmchem Corporation Information
Table 151. Ningbo Inno Pharmchem Description and Major Businesses
Table 152. Ningbo Inno Pharmchem Product Models, Descriptions and Specifications
Table 153. Ningbo Inno Pharmchem Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 154. Ningbo Inno Pharmchem Recent Developments
Table 155. Dayang Chemicals Corporation Information
Table 156. Dayang Chemicals Description and Major Businesses
Table 157. Dayang Chemicals Product Models, Descriptions and Specifications
Table 158. Dayang Chemicals Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 159. Dayang Chemicals Recent Developments
Table 160. Shanghai Lollane Biological Technology Corporation Information
Table 161. Shanghai Lollane Biological Technology Description and Major Businesses
Table 162. Shanghai Lollane Biological Technology Product Models, Descriptions and Specifications
Table 163. Shanghai Lollane Biological Technology Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 164. Shanghai Lollane Biological Technology Recent Developments
Table 165. Dalian Meilun Biotech Corporation Information
Table 166. Dalian Meilun Biotech Description and Major Businesses
Table 167. Dalian Meilun Biotech Product Models, Descriptions and Specifications
Table 168. Dalian Meilun Biotech Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 169. Dalian Meilun Biotech Recent Developments
Table 170. Key Raw Materials Distribution
Table 171. Raw Materials Key Suppliers
Table 172. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 173. Milestones in Production Technology Evolution
Table 174. Distributors List
Table 175. Market Trends and Market Evolution
Table 176. Market Drivers and Opportunities
Table 177. Market Challenges, Risks, and Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Bicyclic Peptide Drugs Product Picture
Figure 2. Global Bicyclic Peptide Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Romidepsin Product Picture
Figure 4. Phalloidin Product Picture
Figure 5. Others Product Picture
Figure 6. Global Bicyclic Peptide Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Anti-Cancer
Figure 8. Antibacterial
Figure 9. Others
Figure 10. Bicyclic Peptide Drugs Report Years Considered
Figure 11. Global Bicyclic Peptide Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 13. Global Bicyclic Peptide Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Bicyclic Peptide Drugs Revenue Market Share by Region (2020-2031)
Figure 15. Global Bicyclic Peptide Drugs Sales (2020-2031) & (Tons)
Figure 16. Global Bicyclic Peptide Drugs Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global Bicyclic Peptide Drugs Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Bicyclic Peptide Drugs Sales Volume Market Share in 2024
Figure 19. Global Bicyclic Peptide Drugs Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Romidepsin Revenue Market Share by Manufacturer in 2024
Figure 22. Phalloidin Revenue Market Share by Manufacturer in 2024
Figure 23. Others Revenue Market Share by Manufacturer in 2024
Figure 24. Global Bicyclic Peptide Drugs Sales Market Share by Type (2020-2031)
Figure 25. Global Bicyclic Peptide Drugs Revenue Market Share by Type (2020-2031)
Figure 26. Global Bicyclic Peptide Drugs Sales Market Share by Application (2020-2031)
Figure 27. Global Bicyclic Peptide Drugs Revenue Market Share by Application (2020-2031)
Figure 28. North America Bicyclic Peptide Drugs Sales YoY (2020-2031) & (Tons)
Figure 29. North America Bicyclic Peptide Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Bicyclic Peptide Drugs Sales Revenue (US$ Million) in 2024
Figure 31. North America Bicyclic Peptide Drugs Sales Volume (Tons) by Type (2020- 2031)
Figure 32. North America Bicyclic Peptide Drugs Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Bicyclic Peptide Drugs Sales Volume (Tons) by Application (2020-2031)
Figure 34. North America Bicyclic Peptide Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Bicyclic Peptide Drugs Sales YoY (2020-2031) & (Tons)
Figure 39. Europe Bicyclic Peptide Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Bicyclic Peptide Drugs Sales Revenue (US$ Million) in 2024
Figure 41. Europe Bicyclic Peptide Drugs Sales Volume (Tons) by Type (2020-2031)
Figure 42. Europe Bicyclic Peptide Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Bicyclic Peptide Drugs Sales Volume (Tons) by Application (2020-2031)
Figure 44. Europe Bicyclic Peptide Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 46. France Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Bicyclic Peptide Drugs Sales YoY (2020-2031) & (Tons)
Figure 51. Asia-Pacific Bicyclic Peptide Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Bicyclic Peptide Drugs Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Bicyclic Peptide Drugs Sales Volume (Tons) by Type (2020- 2031)
Figure 54. Asia-Pacific Bicyclic Peptide Drugs Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Bicyclic Peptide Drugs Sales Volume (Tons) by Application (2020-2031)
Figure 56. Asia-Pacific Bicyclic Peptide Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 61. India Bicyclic Peptide Drugs Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Bicyclic Peptide Drugs Sales YoY (2020-2031) & (Tons)
Figure 63. Central and South America Bicyclic Peptide Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Bicyclic Peptide Drugs Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Bicyclic Peptide Drugs Sales Volume (Tons) by Type (2021-2031)
Figure 66. Central and South America Bicyclic Peptide Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Bicyclic Peptide Drugs Sales Volume (Tons) by Application (2020-2031)
Figure 68. Central and South America Bicyclic Peptide Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Bicyclic Peptide Drugs Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Bicyclic Peptide Drugs Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Bicyclic Peptide Drugs Sales YoY (2020-2031) & (Tons)
Figure 72. Middle East and Africa Bicyclic Peptide Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Bicyclic Peptide Drugs Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Bicyclic Peptide Drugs Sales Volume (Tons) by Type (2021-2031)
Figure 75. South America Bicyclic Peptide Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Bicyclic Peptide Drugs Sales Volume (Tons) by Application (2020-2031)
Figure 77. Middle East and Africa Bicyclic Peptide Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Bicyclic Peptide Drugs Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Bicyclic Peptide Drugs Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Bicyclic Peptide Drugs Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Bicyclic Peptide Drugs Revenue (2020-2025) & (US$ Million)
Figure 82. Bicyclic Peptide Drugs Industry Chain Mapping
Figure 83. Regional Bicyclic Peptide Drugs Manufacturing Base Distribution (%)
Figure 84. Global Bicyclic Peptide Drugs Production Market Share by Region (2020-2031)
Figure 85. Bicyclic Peptide Drugs Production Process
Figure 86. Regional Bicyclic Peptide Drugs Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
